| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 09/16/2009 | CN101531708A Soil protein extraction and intracellular protein separation method |
| 09/16/2009 | CN101531704A Peptide-based compounds |
| 09/16/2009 | CN101530615A Divalent recombinant human papilla virus vaccine |
| 09/16/2009 | CN101530614A Pentavalent recombinant human papilla virus vaccine |
| 09/16/2009 | CN101530612A Type-16 recombinant human papilla virus vaccine |
| 09/16/2009 | CN100541198C Methods for diagnosis and therapy of cancer and composition useful therein |
| 09/16/2009 | CN100540665C Gene regulating plant branching, vector containing the gene, microorganism transformed by the vector, and method for regulating plant branching by using the microorganism |
| 09/16/2009 | CN100540664C Method of transferring mutation into target nucleic acid |
| 09/16/2009 | CN100540566C Analogues of GLP-1 |
| 09/16/2009 | CN100540565C 修饰的Exendins及其应用 Modified Exendins Its Applications |
| 09/16/2009 | CN100540564C Coronal virus genetic engineering protein and use thereof |
| 09/16/2009 | CN100540558C High viscosity xanthan polymer preparations |
| 09/15/2009 | US7589264 Maize variety 36V52 |
| 09/15/2009 | US7589257 Recombinant expression cassettes, host cells, and transgenic plants; ferredoxin NADP+ reductase |
| 09/15/2009 | US7589252 Enhancing the level of expression of a selected heterologous protein in seeds of transgenic plants |
| 09/15/2009 | US7589186 Isolated hOAT polynucleotide |
| 09/15/2009 | US7589185 Nucleotide sequences and protein(s) encoded by such nucleotides for modulation of apoptosis |
| 09/15/2009 | US7589184 Stable protein storage and stable nucleic acid storage in recoverable form |
| 09/15/2009 | US7589183 Prevention of leaching of ligands from affinity-based purification systems |
| 09/15/2009 | US7589178 Fusion polypeptide comprising fibrinopeptide A, serine protease and thrombin-cleavable sequences for use in identifying modulators for prevention and treatment of thrombotic disorders; anticoagulants |
| 09/15/2009 | US7589177 Nucleic acid molecules encoding cyclotide polypeptides and methods of use |
| 09/15/2009 | US7589176 Antifungal polypeptides |
| 09/15/2009 | US7589175 Human OX2 receptors |
| 09/15/2009 | US7589174 GRP94-based compositions and methods of use thereof |
| 09/15/2009 | US7589173 Tumor marker protein that can be used to prepare antibodies that bind to the protein; used to reduce or eliminate metastasis by cancer cells that produce the tumor marker protein |
| 09/15/2009 | US7589172 PRO256 polypeptides |
| 09/15/2009 | US7589167 ZA loops of bromodomains |
| 09/15/2009 | US7589074 Treating inflammatory joint diseases by inhibiting cadherin-11 mediated cellular function; chronic synovitis, autoimmune diseases, rheumatoid arthritis |
| 09/15/2009 | US7589069 Replication-competent anti-cancer vectors |
| 09/15/2009 | US7589062 Cytolytic agents; side effect reduction; Kaposi sarcoma |
| 09/15/2009 | US7589060 Containing fibroblast growth factor or partial peptide active ingredient; promoting follicle growth |
| 09/15/2009 | US7589059 Delivery of molecules and complexes to mammalian cells in vivo |
| 09/15/2009 | US7589058 Ghrelin analogs |
| 09/15/2009 | US7589056 Agent for the prevention and treatment of sexually transmitted diseases-I |
| 09/15/2009 | US7588933 Nucleotide sequences for detecting enterohaemorrhagic Escherichia coli (EHEC) |
| 09/15/2009 | US7588930 Fusing to the antigen a Listerial truncated ActA protein; listeria vaccine strain |
| 09/15/2009 | US7588920 Nucleic acid and amino acid sequences relating to Staphylococcus epidermidis for diagnostics and therapeutics |
| 09/15/2009 | US7588919 Polynucleotide encoding an IL-28B polypeptide |
| 09/15/2009 | US7588918 Mutating one or more of the cysteine residues in the polynucleotide sequences encoding the mature proteins which has antihepatitis activity |
| 09/15/2009 | US7588917 Nucleic acids encoding sugar transport proteins and methods of using same |
| 09/15/2009 | US7588916 Expression vector comprising nucleotide sequences coding g protein coupled receptor for use in identifying modulators of taste preception; artificial sweeteners and enhancement of food flavors |
| 09/15/2009 | US7588915 Isolated genomic polynucleotide fragments from chromosome 7 |
| 09/15/2009 | US7588914 Bacterial Bcl-2 domain-containing polypeptides, encoding nucleic acid molecules, and related methods |
| 09/15/2009 | US7588907 Covalent fluorescence complementation assays for the detection of modified (e.g., ubiquitinated) proteins; drug screening |
| 09/15/2009 | US7588900 Mammalian sweet and amino acid heterodimeric taste receptors |
| 09/15/2009 | US7588888 DNA encoding a plant deoxyhypusine synthase, a plant eukaryotic initiation factor 5A, transgenic plants and a method for controlling senescence programmed and cell death in plants |
| 09/15/2009 | US7588773 vaccines; use for detecting a group B streptococcus serotype III, RDP III-3 strain; drug screen an agent for inhibiting adhesion of a group B streptococcal cell to a host cell |
| 09/15/2009 | US7588770 Recombinant viruses of the paramyxoviridae family with heterologous envelope glycoproteins |
| 09/15/2009 | US7588769 Recombinant influenza virus comprising a mutant membrane protein gene, e.g., a mutant integral membrane protein gene such as a mutant type III integral membrane protein gene, which does not encode a functional membrane protein or a functional portion thereof; use in gene therapy |
| 09/15/2009 | US7588768 Attenuated negative strand viruses with altered interferon antagonist activity for use as vaccines and pharmaceuticals |
| 09/15/2009 | US7588765 Coupling a endotoxin (LPS) free polyfunctional polysaccharide with a polyfunctional carrier protein with quantitative yields; vaccine comprising a glycoconjugate antigen specific for Neisseria meningitidis |
| 09/15/2009 | US7588764 Compositions comprising human immunodeficiency virus Tat adsorbed to the surface of anionic nanoparticles |
| 09/15/2009 | US7588763 Methods for the prevention against or treatment of diabetes with ETXB and/or insulin |
| 09/15/2009 | US7588762 Streptoccal inhibitor of complement-mediated lysis, protein SIC |
| 09/15/2009 | US7588756 Administering intracoronally a compatible auxiliary or support and a nucleic acid encoding a polypeptide S100A1 protein; increases the systolic Ca2+ release from the sarcoplasmic reticulum and increases the rate of Ca2+ uptake into the sarcoplasmic reticulum |
| 09/15/2009 | US7588755 Immunomodulation by administration of a recombinant polypeptide produced by a non-human host transformed by a recombinant DNA molecule ; antiviral and antitumor or anticancer agents |
| 09/15/2009 | US7588752 Derived from milk protein casein; for use in dentistry |
| 09/15/2009 | CA2371462C Modified protein matrices |
| 09/15/2009 | CA2369616C Somatic transgene immunization and related methods |
| 09/15/2009 | CA2348828C Genomic and complete cdna sequences of apm1 and biallelic markers thereof |
| 09/15/2009 | CA2270423C Prophylactic/therapeutic agent |
| 09/15/2009 | CA2156272C Dna encoding a human neuropeptide y/peptide yy/pancreatic polypeptide receptor (y4) and uses thereof |
| 09/15/2009 | CA2149925C Peptidic derivates of .alpha.-msh and their uses |
| 09/15/2009 | CA2032158C Multivalent repressor of gene function |
| 09/11/2009 | WO2009111781A2 Chimeric c3-like rho antagonist bone therapeutic |
| 09/11/2009 | WO2009111599A2 Plasmodium malariae and plasmodium ovale genes and uses thereof |
| 09/11/2009 | WO2009111444A1 Modulation of srpx2-mediated angiogenesis |
| 09/11/2009 | WO2009111347A1 Purified immunoglobulin fusion proteins and methods of their purification |
| 09/11/2009 | WO2009110796A1 Production of itaconic acid |
| 09/11/2009 | WO2009109860A2 Mutant forms of chlamydia htra |
| 09/11/2009 | WO2009109662A1 Diagnosis of and vaccination against aspergillus fumigatus |
| 09/11/2009 | WO2009109643A2 Use of interleukin-1 conjugates in the treatment of diabetes |
| 09/11/2009 | WO2009109532A2 Use of defensins against tuberculosis |
| 09/11/2009 | WO2009109428A2 Self-assembling peptide nanoparticles useful as vaccines |
| 09/11/2009 | WO2009109363A1 Composition for treating or preventing streptococcal infections |
| 09/11/2009 | WO2009109359A1 Protein or glycoprotein from haliotis midae and its use as an immunotherapy agent |
| 09/11/2009 | WO2009109156A2 Novel antimicrobial peptides and their application |
| 09/11/2009 | WO2009109129A1 A new type of consensus interferon and preparation method thereof |
| 09/11/2009 | WO2009109123A1 An artificial synthesized insecticidal gene and the protein encoded by same and uses thereof |
| 09/11/2009 | WO2009090553A3 Compositions and methods of detecting post-stop peptides |
| 09/11/2009 | WO2009088255A3 Method for preparing antigen effective for preventing anthrax infection |
| 09/11/2009 | WO2009086131A4 Bmp mutants with decreased susceptibility to noggin |
| 09/11/2009 | WO2009079481A3 Methods to diagnose and immunize against the virus causing human merkel cell carcinoma |
| 09/11/2009 | WO2009077546A3 Lipid metabolism protein and uses thereof ii (phosphate transporter) |
| 09/11/2009 | WO2009075836A3 Rap variants for drug delivery |
| 09/11/2009 | WO2009067642A3 Removing polypeptides from stool |
| 09/11/2009 | WO2009067639A4 Variants of c-type natriuretic peptide |
| 09/11/2009 | WO2009059305A3 Red fluorescent proteins with enhanced bacterial expression, increased brightness and reduced aggregation |
| 09/11/2009 | WO2009052323A3 Manufacture, compositions and uses of coagulationfactor viia modulator |
| 09/11/2009 | WO2009032702A3 Synthetic apolipoprotein e mimicking polypeptides and methods of use |
| 09/11/2009 | WO2009030065A8 INTERFERON ALPHA 2a MODIFIED BY POLYETHYLENE GLYCOL, ITS SYNTHESIS PROCESS AND APPLICATION |
| 09/11/2009 | WO2008115880A3 Use of leptin for the treatment or prevention of parkinson's disease |
| 09/11/2009 | WO2008046107A9 Novel inhibitors of the egfr kinase targeting the asymmetric activating dimer interface |
| 09/11/2009 | WO2007098420A8 Peptides that block the binding of igg to fcrn |
| 09/11/2009 | WO2006108658A3 Process for the production of monoclonal antibodies using chimeric vlps |
| 09/11/2009 | CA2717736A1 Modulation of srpx2-mediated angiogenesis |
| 09/11/2009 | CA2717129A1 Purified immunoglobulin fusion proteins and methods of their purification |
| 09/11/2009 | CA2717108A1 Use of interleukin-1 conjugates in the treatment of diabetes |
| 09/11/2009 | CA2717006A1 Use of defensins against tuberculosis |
| 09/11/2009 | CA2713879A1 Self-assembling peptide nanoparticles useful as vaccines |